EDITORIAL
Published on 09 Dec 2020
Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy
doi 10.3389/fonc.2020.628005
- 2,606 views
- 4 citations
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Bispecific Antibodies for T-Cell Based Immunotherapy
Bispecific Antibodies for T-Cell Based Immunotherapy
19k
Total downloads
85k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 30 Nov 2020
Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity
doi 10.3389/fonc.2020.575737
- 9,260 views
- 38 citations
REVIEW
Published on 07 May 2020
Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies
doi 10.3389/fimmu.2020.00762
- 20,624 views
- 65 citations
ORIGINAL RESEARCH
Published on 05 May 2020
Anti-CS1 × Anti-CD3 Bispecific Antibody (BiAb)-Armed Anti-CD3 Activated T Cells (CS1-BATs) Kill CS1+ Myeloma Cells and Release Type-1 Cytokines
doi 10.3389/fonc.2020.00544
- 3,442 views
- 15 citations
REVIEW
Published on 24 Apr 2020
Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions
doi 10.3389/fimmu.2020.00501
- 27,247 views
- 85 citations
PERSPECTIVE
Published on 15 Apr 2020
Perspective: Designing T-Cell Engagers With Better Therapeutic Windows
doi 10.3389/fonc.2020.00446
- 29,341 views
- 60 citations
ORIGINAL RESEARCH
Published on 13 Nov 2019
A Novel Fully-Human Potency-Matched Dual Cytokine-Antibody Fusion Protein Targets Carbonic Anhydrase IX in Renal Cell Carcinomas
doi 10.3389/fonc.2019.01228
- 4,181 views
- 14 citations
Published in
Frontiers in Oncology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Impact
- 85kTopic views
- 64kArticle views
- 19kArticle downloads